# Bolt Biotherapeutics Inc. (BOLT)

**Exchange:** NASDAQ  
**Market cap:** $8M  
**Price:** $4.43 (-4.11%)

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $8M | — | -$36M | -$33M | — |
| 2024 | $8M | — | -$73M | -$63M | — |
| 2023 | $8M | — | -$76M | -$69M | — |
| 2022 | $6M | — | -$90M | -$88M | — |
| 2021 | $1M | — | -$93M | -$99M | — |
| 2020 | $231,000 | — | -$49M | -$61M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $57M | $30M | $27M | $12M | — |
| 2024 | $100M | $42M | $57M | $7M | — |
| 2023 | $160M | $47M | $113M | $11M | — |
| 2022 | $228M | $56M | $172M | $9M | — |
| 2021 | $308M | $58M | $250M | $27M | — |
| 2020 | $47M | $46M | -$105M | $6M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$40M | $72,000 | -$40M |
| 2024 | -$61M | $41,000 | -$61M |
| 2023 | -$70M | $206,000 | -$70M |
| 2022 | -$77M | $2M | -$78M |
| 2021 | -$57M | $2M | -$59M |
| 2020 | -$47M | $3M | -$51M |

Source: [CompaniesByCap](https://companiesbycap.com/company/BOLT)